封面
市场调查报告书
商品编码
1726404

全球微生物附着量测试市场:市场规模、份额、趋势分析(按产品、测试类型、应用、最终用途和地区)、细分市场预测(2025-2030 年)

Bioburden Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test Type, By Application (Raw Material Testing), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

微生物附着量测试市场的成长和趋势:

根据Grand View Research, Inc.的最新报告,全球微生物附着量测试市场规模预计到2030年将达到32.2亿美元,预计2025年至2030年期间的复合年增长率为14.5%。

由于人们对产品安全的担忧日益加剧,预计未来几年市场将呈现上升趋势。为此,政府正在采取各种措施来推广微生物安全检测工具。

许多组织发表了大量出版物来提高人们对微生物安全测试的认识,并拓宽了微生物附着量测试的未来发展前景。例如,美国卫生与公众服务部和疾病管制中心出版了《微生物和生物医学实验室的生物安全》(BMBL),其中包含与实验室生物安全和风险评估、净化和灭菌、生物毒素和实验室生物安全水平相关的资讯。

製药、生物技术、医疗设备以及食品饮料行业的成长推动了微生物附着量测试市场的快速成长。此外,知名公司增加研发投入预计将鼓励最终用户采用高效的微生物附着量测试工具来应对因微生物污染造成的损失。此外,临床前试验中对基本药物安全数据的需求预计将推动对微生物附着量测试工具的需求。

微生物附着量测试市场:分析概述

  • 耗材在微生物附着量测试市场占据主导地位,2024 年占据最高收益占有率,为 66.4%。此部分进一步分为培养基、试剂和套件。
  • 需气菌计数检测将引领微生物附着量检测市场,到 2024 年将占据最大的收益占有率,达到 36.6%。
  • 原料测试部分将主导微生物附着量测试市场,2024 年的最大收益占有率为 30.4%。
  • 製药和生物技术公司将主导微生物附着量测试市场,占据 2024 年最大的收益占有率。

目录

第一章 分析方法与范围

第二章执行摘要

第三章微生物附着量测试市场:驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • 产业分析:波特五力分析
    • PESTEL分析

第四章微生物附着量测试市场:按产品分類的业务分析

  • 各产品市场占有率(2024 年及 2030 年)
  • 产品仪表板
  • 市场规模预测及产品趋势分析(2018-2030)
  • 耗材
  • 装置

第五章微生物附着量测试市场:按测试类型进行的业务分析

  • 按测试类型分類的市场占有率(2024 年和 2030 年)
  • 考试类型仪表板
  • 按测试类型分類的市场规模预测和趋势分析(2018-2030)
  • 需气菌计数检测
  • 厌氧菌计数检测
  • 真菌/霉菌计数测试
  • 孢子计数测试

第六章微生物附着量测试市场:按应用进行的业务分析

  • 按应用分類的市场占有率(2024 年和 2030 年)
  • 特定于应用程式的仪表板
  • 按应用分類的市场规模预测和趋势分析(2018-2030)
  • 原料检测
  • 医疗设备测试
  • 进程内的材料测试
  • 灭菌验证测试
  • 设备清洗验证

第七章微生物附着量测试市场:依最终用途的业务分析

  • 按最终用途分類的市场占有率(2024 年和 2030 年)
  • 最终用途仪表板
  • 按最终用途分類的市场规模预测和趋势分析(2018-2030 年)
  • 製药和生物技术公司
  • 製药和生物技术市场(2018-2030)
  • 医疗设备製造商
  • 契约製造组织
  • 食品饮料及农产品製造商
  • 微生物实验室

第八章微生物附着量测试市场:按地区估计和趋势分析

  • 各地区市场占有率(2024 年及 2030 年)
  • 区域市场仪表板
  • 市场规模预测及趋势分析(2018-2030年)
  • 北美洲
    • 按国家/地区(2018-2030 年)
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区(2018-2030 年)
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 按国家/地区(2018-2030 年)
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 按国家/地区(2018-2030 年)
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区(2018-2030 年)
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 市场参与企业概况
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Charles River Laboratories
    • Merck KGaA
    • SGS SA
    • WuXi AppTec
    • BD
    • North American Science Associates Inc.
    • Nelson Laboratories, LLC
    • Thermo Fisher Scientific Inc.
    • BIOMERIEUX
    • Pacific Biolabs
Product Code: GVR-3-68038-774-2

Bioburden Testing Market Growth & Trends:

The global bioburden testing market size is estimated to reach USD 3.22 billion by 2030, registering to grow at a CAGR of 14.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The market is expected to showcase upward trend in the forthcoming years owing to growing concerns about product safety. This has led to various government initiatives to promote microbiological safety testing tools.

A number of publications released by organizations to promote awareness regarding microbiological safety testing is broadening the future growth prospects of bioburden testing. For instance, the U.S. Department of Health and Human Services and Centers for Disease Control published Biosafety in Microbiological and Biomedical Laboratories (BMBL), which includes information pertaining to laboratory biosecurity and risk assessment, decontamination and sterilization, and biological toxins and biosafety levels in laboratories.

Growth of pharmaceutical, biotechnology, medical device, and food and beverage industries have contributed to the high growth of the bioburden testing market. In addition, increase in R&D investments by prominent companies is expected to encourage end users to adopt highly efficient bioburden testing tools to counter possible losses due to microbial contamination. Moreover, requirement for basic drug safety data requirements for preclinical studies is expected to fuel the demand for bioburden testing tools.

Bioburden Testing Market Report Highlights:

  • Consumables dominated the bioburden testing market, accounting for the highest revenue share of 66.4% in 2024. The segment is further divided into culture media, reagents, and kits.
  • Aerobic count testing led the bioburden testing market, accounting for the largest revenue share of 36.6% in 2024.
  • The raw material testing sector dominated the bioburden testing market, with the largest revenue share of 30.4% in 2024.
  • Pharmaceutical and biotechnology companies dominated the bioburden testing market with the largest revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Test Type
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Bioburden Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Bioburden Testing Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.2. Culture Media
      • 4.4.2.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.3. Reagents and Kits
      • 4.4.3.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.5.2. Automated Microbial Identification Systems
      • 4.5.2.1. Automated Microbial Identification Systems Market, 2018 - 2030 (USD Million)
    • 4.5.3. PCR Instruments
      • 4.5.3.1. PCR Instruments Market, 2018 - 2030 (USD Million)

Chapter 5. Bioburden Testing Market: Test Type Business Analysis

  • 5.1. Test Type Market Share, 2024 & 2030
  • 5.2. Test Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
  • 5.4. Aerobic Count Testing
    • 5.4.1. Aerobic Count Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Anaerobic Count Testing
    • 5.5.1. Anaerobic Count Testing Market, 2018 - 2030 (USD Million)
  • 5.6. Fungi/Mold Count Testing
    • 5.6.1. Fungi/Mold Count Testing Market, 2018 - 2030 (USD Million)
  • 5.7. Spore Count Testing
    • 5.7.1. Spore Count Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Bioburden Testing Market: Application Business Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Raw Material Testing
    • 6.4.1. Raw Material Testing Market, 2018 - 2030 (USD Million)
  • 6.5. Medical Device Testing
    • 6.5.1. Medical Device Testing Market, 2018 - 2030 (USD Million)
  • 6.6. In-Process Material Testing
    • 6.6.1. In-Process Material Testing Market, 2018 - 2030 (USD Million)
  • 6.7. Sterilization Validation Testing
    • 6.7.1. Sterilization Validation Testing Market, 2018 - 2030 (USD Million)
  • 6.8. Equipment Cleaning Validation
    • 6.8.1. Equipment Cleaning Validation Market, 2018 - 2030 (USD Million)

Chapter 7. Bioburden Testing Market: End Use Business Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
  • 7.5. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.6. Medical Device Manufacturers
    • 7.6.1. Medical Device Manufacturers Market, 2018 - 2030 (USD Million)
  • 7.7. Contract Manufacturing Organizations
    • 7.7.1. Contract Manufacturing Organizations Market, 2018 - 2030 (USD Million)
  • 7.8. Manufacturers of Food & Beverage and Agricultural Products
    • 7.8.1. Manufacturers of Food & Beverage and Agricultural Products Market, 2018 - 2030 (USD Million)
  • 7.9. Microbial Testing Laboratories
    • 7.9.1. Microbial Testing Laboratories Market, 2018 - 2030 (USD Million)

Chapter 8. Bioburden Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Denmark Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Sweden Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Norway Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. Australia Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. South Korea Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Bioburden Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Bioburden Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Charles River Laboratories
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Merck KGaA
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. SGS SA
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. WuXi AppTec
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. BD
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. North American Science Associates Inc.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Nelson Laboratories, LLC
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Thermo Fisher Scientific Inc.
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. BIOMERIEUX
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Pacific Biolabs
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global bioburden testing market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 6. Global bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 7. Global bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8. North America bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 9. North America bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 10. North America bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 11. North America bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 12. North America bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 13. U.S. bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 14. U.S. bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 15. U.S. bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 16. U.S. bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Canada bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 18. Canada bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 19. Canada bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 20. Canada bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 21. Mexico bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 22. Mexico bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 23. Mexico bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 24. Mexico bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Europe bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 26. Europe bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 27. Europe bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 28. Europe bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 29. Europe bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30. UK bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 31. UK bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 32. UK bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 33. UK bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Germany bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 35. Germany bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 36. Germany bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 37. Germany bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 38. France bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 39. France bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 40. France bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 41. France bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Italy bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 43. Italy bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 44. Italy bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 45. Italy bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Spain bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 47. Spain bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 48. Spain bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 49. Spain bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50. Denmark bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 51. Denmark bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 52. Denmark bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 53. Denmark bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Sweden bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 55. Sweden bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 56. Sweden bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 57. Sweden bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 58. Norway bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 59. Norway bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 60. Norway bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 61. Norway bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 67. Japan bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 68. Japan bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 69. Japan bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 70. Japan bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 71. China bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 72. China bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 73. China bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 74. China bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75. India bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 76. India bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 77. India bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 78. India bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79. Australia bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 80. Australia bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 81. Australia bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 82. Australia bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 83. South Korea bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 84. South Korea bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 85. South Korea bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 86. South Korea bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Thailand bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 88. Thailand bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 89. Thailand bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 90. Thailand bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 91. Latin America bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 92. Latin America bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 93. Latin America bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 94. Latin America bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 95. Latin America bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 96. Brazil bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 97. Brazil bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 98. Brazil bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 99. Brazil bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 100. Argentina bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 101. Argentina bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 102. Argentina bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 103. Argentina bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 104. MEA bioburden testing market, by country, 2018 - 2030 (USD Million)
  • Table 105. MEA bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 106. MEA bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 107. MEA bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 108. MEA bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 109. South Africa bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 110. South Africa bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 111. South Africa bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 112. South Africa bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 117. UAE bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 118. UAE bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 119. UAE bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 120. UAE bioburden testing market, by end use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait bioburden testing market, by product, 2018 - 2030 (USD Million)
  • Table 122. Kuwait bioburden testing market, by test type, 2018 - 2030 (USD Million)
  • Table 123. Kuwait bioburden testing market, by application, 2018 - 2030 (USD Million)
  • Table 124. Kuwait bioburden testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Bioburden testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product outlook (USD Million)
  • Fig. 10 Test type outlook (USD Million)
  • Fig. 11 Application outlook (USD Million)
  • Fig. 12 End use outlook (USD Million)
  • Fig. 13 Competitive landscape
  • Fig. 14 Bioburden testing market dynamics
  • Fig. 15 Bioburden testing market: Porter's five forces analysis
  • Fig. 16 Bioburden testing market: Pestle analysis
  • Fig. 17 Bioburden testing market: Product segment dashboard
  • Fig. 18 Bioburden testing market: Product market share analysis, 2024 & 2030
  • Fig. 19 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 20 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 21 Bioburden testing market: Test type segment dashboard
  • Fig. 22 Bioburden testing market: Test type market share analysis, 2024 & 2030
  • Fig. 23 Aerobic count testing market, 2018 - 2030 (USD Million)
  • Fig. 24 Anaerobic count testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Fungi/Mold count testing market, 2018 - 2030 (USD Million)
  • Fig. 26 Spore count testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Bioburden testing market: Application segment dashboard
  • Fig. 28 Bioburden testing market: Application market share analysis, 2024 & 2030
  • Fig. 29 Raw material testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Medical device testing market, 2018 - 2030 (USD Million)
  • Fig. 31 In-process material testing market, 2018 - 2030 (USD Million)
  • Fig. 32 Sterilization validation testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Equipment cleaning validation market, 2018 - 2030 (USD Million)
  • Fig. 34 Bioburden testing market: End use segment dashboard
  • Fig. 35 Bioburden testing market: End use market share analysis, 2024 & 2030
  • Fig. 36 Pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 37 Medical device manufacturers market, 2018 - 2030 (USD Million)
  • Fig. 38 Contract manufacturing organizations market, 2018 - 2030 (USD Million)
  • Fig. 39 Manufacturers of food & beverage and agricultural products market, 2018 - 2030 (USD Million)
  • Fig. 40 Microbial testing laboratories market, 2018 - 2030 (USD Million)
  • Fig. 41 Bioburden testing market revenue, by region
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. country dynamics
  • Fig. 46 U.S. bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada country dynamics
  • Fig. 48 Canada bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico country dynamics
  • Fig. 50 Mexico bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 51 Europe bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 52 UK country dynamics
  • Fig. 53 UK bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 54 Germany country dynamics
  • Fig. 55 Germany bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 56 France country dynamics
  • Fig. 57 France bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy country dynamics
  • Fig. 59 Italy bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 60 Spain country dynamics
  • Fig. 61 Spain bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden country dynamics
  • Fig. 65 Sweden bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 69 Japan country dynamics
  • Fig. 70 Japan bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 71 China country dynamics
  • Fig. 72 China bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 73 India country dynamics
  • Fig. 74 India bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Australia country dynamics
  • Fig. 76 Australia bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea country dynamics
  • Fig. 78 South Korea bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 79 Thailand country dynamics
  • Fig. 80 Thailand bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 82 Brazil country dynamics
  • Fig. 83 Brazil bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina country dynamics
  • Fig. 85 Argentina bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 86 MEA bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa country dynamics
  • Fig. 88 South Africa bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia country dynamics
  • Fig. 90 Saudi Arabia bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 91 UAE country dynamics
  • Fig. 92 UAE bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 93 Kuwait country dynamics
  • Fig. 94 Kuwait bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 95 Company categorization
  • Fig. 96 Company market position analysis
  • Fig. 97 Strategic framework